Shinji Futami
Overview
Explore the profile of Shinji Futami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T, et al.
Sci Rep
. 2024 Aug;
14(1):17917.
PMID: 39095551
Chimeric antigen receptor (CAR) T cells are effective against hematological cancers, but are less effective against solid tumors such as non-small cell lung cancer (NSCLC). One of the reasons is...
2.
Ando S, Futami S, Azuma K, Nishimatsu K, Shirasaka T, Minami S
J Med Cases
. 2024 Aug;
15(8):153-158.
PMID: 39091578
Various driver mutations and the corresponding molecular-targeted drugs have been detected and developed in non-small cell lung cancer. There were many cases in which surgical specimens had happened to find...
3.
Ando S, Azuma K, Futami S, Mori K, Hirose Y, Shirasaka T, et al.
J Med Cases
. 2024 Jul;
15(7):120-125.
PMID: 38993806
Kampo medicine, a traditional Japanese herbal medicine, is covered by the Japanese National Health Insurance and prescribed for various purposes. While relatively safe with few adverse effects, it may potentially...
4.
Enomoto T, Shirai Y, Takeda Y, Edahiro R, Shichino S, Nakayama M, et al.
JCI Insight
. 2024 Jun;
9(11).
PMID: 38855869
Progressive pulmonary fibrosis (PPF), defined as the worsening of various interstitial lung diseases (ILDs), currently lacks useful biomarkers. To identify novel biomarkers for early detection of patients at risk of...
5.
Yoshimura H, Takeda Y, Shirai Y, Yamamoto M, Nakatsubo D, Amiya S, et al.
J Allergy Clin Immunol
. 2024 Mar;
153(5):1268-1281.
PMID: 38551536
Background: Novel biomarkers (BMs) are urgently needed for bronchial asthma (BA) with various phenotypes and endotypes. Objective: We sought to identify novel BMs reflecting tissue pathology from serum extracellular vesicles...
6.
Satoh S, Miyake K, Adachi Y, Masuhiro K, Futami S, Naito Y, et al.
Biochem Biophys Res Commun
. 2024 Jan;
696:149511.
PMID: 38241813
RNA splicing is a fundamental cellular mechanism performed by spliceosomes that synthesise multiple mature RNA isoforms from a single gene. The association between spliceosome abnormality and solid cancers remains largely...
7.
Naito M, Fukushima K, Kusakabe S, Endo T, Shiroyama T, Ohira K, et al.
BMC Infect Dis
. 2023 Aug;
23(1):517.
PMID: 37550642
Background: Mycobacterium obuense (M. obuense) is a rapidly growing mycobacterium (RGM) which has been considered nonpathogenic. Here, we report a case of disseminated non-tuberculous mycobacterial (NTM) infection caused by M....
8.
Tone M, Iwahori K, Shiroyama T, Futami S, Naito Y, Fukushima K, et al.
Sci Rep
. 2023 May;
13(1):8313.
PMID: 37221285
Minocycline is often administered prophylactically or therapeutically to non-small cell lung cancer (NSCLC) patients receiving epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) for skin rash as an adverse event. We...
9.
Futami Y, Takeda Y, Koba T, Narumi R, Nojima Y, Ito M, et al.
Int Immunol
. 2022 Mar;
34(6):327-340.
PMID: 35294531
Sarcoidosis is a complex, polygenic, inflammatory granulomatous multi-organ disease of unknown cause. The granulomatous inflammation in sarcoidosis is driven by the interplay between T cells and macrophages. Extracellular vesicles (EVs)...
10.
Fukushima K, Tsujino K, Futami S, Kida H
Int J Mol Sci
. 2020 Feb;
21(3).
PMID: 32046322
In autoantibody-mediated autoimmune diseases, pathogenic autoantibodies generated by a failure of central or peripheral tolerance, have different effects mediated by a variety of mechanisms. Interestingly, even non-autoimmune chronic diseases have...